FL Attorney General Bondi Files Suit Against CVS and Walgreens for Role in Opioid Crisis

Monday, November 19, 2018

 

View Larger +

CVS "failed in their duties under Florida law"

Florida Attorney General Pam Bondi has filed an amended complaint in the Pasco County Circuit Court action against opioid manufacturers and distributors.

The amended complaint provides additional details of the defendants’ collective efforts to increase the supply of opioids in Florida and nationwide. Insys Therapeutics, Inc., Walgreens Co., CVS Healthcare Corp. and CVS Pharmacy, Inc. (“CVS”) are named as additional defendants for their roles in creating the opioid crisis.

The amended complaint alleges that Walgreens Co. and CVS were two of the largest opioid distributors in Florida and failed in their duties under Florida law to stop suspicious orders of opioids they received. The amended complaint also alleges that Walgreens Co. and CVS dispensed unreasonable quantities of opioids from their pharmacies.

GET THE LATEST BREAKING NEWS HERE -- SIGN UP FOR GOLOCAL FREE DAILY EBLAST

“We will continue to pursue those companies that played a role in creating the opioid crisis,” said Bondi. “Thousands of Floridians have suffered as a result of the actions of the defendants.”

The amended complaint alleges that Insys Therapeutics, Inc. provided kickbacks to doctors in exchange for doctors writing prescriptions for its opioid product, Subsys.

In the amended complaint, the Attorney General’s Office added claims for gross negligence and civil conspiracy against the defendants.

CVS spokesman Mike DeAngelis called the lawsuit "without merit" in comments to NBC News.

On Tuesday, May 15, 2018, Bondi filed her original action in state court against some of the nation’s largest opioid manufacturers and distributors for their role in the opioid crisis. 

 

Related Slideshow: CVS - Aetna Deal - Key Slides from Deal, Dec, 2017

 
 

Enjoy this post? Share it with others.

 
 

Sign Up for the Daily Eblast

I want to follow on Twitter

I want to Like on Facebook